Skip to main content

Bruce D Hammock

NIH Rank #4692
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1888041Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$2.5M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#4,692
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bruce D Hammock. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Bruce D Hammock as a PI. Multi-PI records show the full award amount for context.

  • 5UH3DA048767-04UH3
    Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
    $2.5M
    award amount

Award organization

Organizations that administered FY2025 awards listing Bruce D Hammock as a PI.

FY2025 award administered by Eicosis, Llc (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Eicosis, Llc
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1896
  6. 2024
    Entered Top 25% Nationally
    Ranked #1896
  7. 2024
    Entered Top 10% Nationally
    Ranked #1896
  8. 2025
    $5M Cumulative Funding